Clinical trials are the backbone of medical progress, but a worrying trend is emerging: a large portion end without delivering useful results. This “uninformativeness” wastes valuable resources and delays advancements.
Fast Data Science is excited to announce the publication of a technical research paper the Clinical Trial Risk Tool, a game-changer in identifying potential uninformativeness at the protocol stage!
The Clinical Trial Risk Tool is a browser-based tool which uses Natural Language Processing (NLP) to analyse clinical trial protocols. Here’s how it works:
Ready to fight uninformativeness? Head over to https://clinicaltrialrisk.org/tool and access this free, open-source software.
A BibTex citation is as follows:
@article{wood2023clinical,
title={Clinical Trial Risk Tool: software application using natural language processing to identify the risk of trial uninformativeness},
author={Wood, Thomas A and McNair, Douglas},
journal={Gates Open Research},
volume={7},
number={56},
pages={56},
year={2023},
publisher={F1000 Research Limited}
}
Read more about research in AI and Fast Data Science’s publications here
Looking for experts in Natural Language Processing? Post your job openings with us and find your ideal candidate today!
Post a Job
Thomas Wood presents the Clinical Trial Risk Tool before the November meeting of the Clinical AI Interest Group at Alan Turing Institute The Clinical AI Interest group is a community of health professionals from a broad range of backgrounds with an interest in Clinical AI, organised by the Alan Turing Institute.
Fast Data Science will appear at Ireland’s Expert Witness Conference on 20 May 2026 in Dublin On 20 May 2026, La Touche Training is running the Expert Witness Conference 2026, at the Radisson Blu Hotel, Golden Lane, Dublin 8, Ireland. This is a full-day event combining practical workshops and interactive sessions, aimed at expert witnesses and legal professionals who want to enhance their expertise. The agenda covers critical topics like recent developments in case law, guidance on report writing, and techniques for handling cross-examination.
Guest post by Alex Nikic In the past few years, Generative AI technology has advanced rapidly, and businesses are increasingly adopting it for a variety of tasks. While GenAI excels at tasks such as document summarisation, question answering, and content generation, it lacks the ability to provide reliable forecasts for future events. GenAI models are not designed for forecasting, and along with the tendancy to hallucinate information, the output of these models should not be trusted when planning key business decisions. For more details, a previous article on our blog explores in-depth the trade-offs of GenAI vs Traditional Machine Learning approaches.
What we can do for you